Survival in Duchenne muscular dystrophy

Area of Science:

• Neurology
• Genetics
• Public Health

Background:

• Duchenne muscular dystrophy (DMD) is a severe genetic disorder affecting muscle function.
• Understanding survival trends in specific populations is crucial for patient care and resource allocation.

Purpose of the Study:

• To determine the survival rates and influencing factors in a cohort of German patients diagnosed with Duchenne muscular dystrophy.
• To provide updated survival data for Duchenne muscular dystrophy patients in Germany.

Main Methods:

• A cohort of 94 German patients born between 1970 and 1980 with Duchenne muscular dystrophy was studied.
• Data on survival, clinical course, and medical interventions were collected via telephone interviews and questionnaires.
• Patients were stratified by molecular confirmation of diagnosis and year of death (pre- and post-2000).

Main Results:

• Patients with molecularly confirmed Duchenne muscular dystrophy (n=67) had a median survival of 24.0 years.
• Patients without molecular confirmation had a 67% chance of reaching 24 years of age.
• Ventilator use was a key intervention, with ventilated patients achieving a median survival of 27.0 years, compared to 19.0 years for non-ventilated patients.

Conclusions:

• This study provides valuable, stratified survival data for German Duchenne muscular dystrophy patients.
• Molecular confirmation of diagnosis is associated with specific survival outcomes.
• Mechanical ventilation significantly improves median survival in Duchenne muscular dystrophy patients.